Maximus, Inc. $MMS Shares Purchased by WINTON GROUP Ltd

Key Points

• WINTON GROUP Ltd increased its Maximus stake by 1,992.2% in the second quarter, purchasing 79,687 additional shares for a total position worth approximately $4.5 million. Institutional investors collectively own 97.21% of the company.
• Maximus reported quarterly EPS of $2.22, slightly above analyst estimates, but revenue fell 5.1% year over year to $1.28 billion and missed expectations. The company issued fiscal 2026 EPS guidance of $7.90–$8.20.
• The stock traded at $56.58, while analysts maintained a cautious outlook, with ratings ranging from “Hold” to “Strong Sell” and an overall MarketBeat consensus of “Reduce.” Maximus also pays a quarterly dividend of $0.33 per share, yielding about 2.3%.

WINTON GROUP Ltd raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 1,992.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 83,687 shares of the health services provider's stock after purchasing an additional 79,687 shares during the quarter. WINTON GROUP Ltd owned about 0.16% of Maximus worth $4,499,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in MMS. Empowered Funds LLC acquired a new position in Maximus during the 2nd quarter worth $504,000. Reinhart Partners LLC. grew its stake in shares of Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock worth $106,575,000 after purchasing an additional 1,127,346 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Maximus during the second quarter valued at $1,719,000. Dimensional Fund Advisors LP increased its holdings in shares of Maximus by 7.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider's stock valued at $135,084,000 after purchasing an additional 141,362 shares during the period. Finally, Walleye Capital LLC bought a new stake in shares of Maximus during the second quarter valued at about $20,645,000. Institutional investors own 97.21% of the company's stock.

Maximus Trading Up 0.8%

Shares of NYSE:MMS opened at $56.58 on Friday. The stock has a market capitalization of $2.96 billion, a price-to-earnings ratio of 8.36 and a beta of 0.59. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The company has a 50 day moving average price of $58.09 and a 200 day moving average price of $62.43.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.33 billion. During the same quarter in the prior year, the company earned $2.16 earnings per share. The firm's revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, research analysts anticipate that Maximus, Inc. will post 8.03 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. Maximus's payout ratio is 19.50%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MMS. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Zacks Research downgraded shares of Maximus from a "hold" rating to a "strong sell" rating in a research report on Tuesday, August 11th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Maximus in a research note on Monday, August 17th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Reduce".

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.